Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Photoreceptors and Visual Pathways

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Multidrug-resistant Staphylococcus hominis endophthalmitis after cataract surgery: A case report.

IDCases·2026

Same author

Monitoring cancer-related fatigue and quality of life in breast and prostate cancer patients after primary treatment: a study protocol for the REBECCA trials in Norway.

Clinical and experimental medicine·2026

Same author

Bilateral Keratoconus: a Cataract Preoperative Assessment Incidental Finding. Role of Tomography in Biometry and Multifocality of Cone Effect.

Maedica·2026

Same author

Services for Connected, Cooperated, and Automated Mobility based on Big Data and Artificial Intelligence: The SHOW project paradigm.

Open research Europe·2025

Same author

Prophylactic Laser and Cryotherapy in the Fellow Eye of Patients With Giant Retinal Tears: A Systematic Review and Meta-Analysis.

Cureus·2025

Same author

Structural Changes in Retinal Vein Occlusion: Implications for Functional Outcomes and Visual Field Deficits.

Maedica·2025

Search research articles

Related Experiment Video

Updated: May 27, 2025

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Published on: August 6, 2021

Ocular and Genetic Risk Factors in Branch Retinal Vein Occlusion: a Comprehensive Review.

Christina Garnavou-Xirou^1,2, Georgios Bontzos¹, Georgios Smoustopoulos¹

¹Department of Ophthalmology, Korgialenio-Benakio General Hospital, Athens, Greece.

|February 20, 2025

Summary

Branch retinal vein occlusion (BRVO) is a common cause of vision loss. Ocular conditions like glaucoma and genetic factors significantly increase BRVO risk, necessitating targeted prevention strategies.

More Related Videos

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

Published on: April 21, 2022

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

Published on: August 11, 2023

Related Experiment Videos

Last Updated: May 27, 2025

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Published on: August 6, 2021

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

Published on: April 21, 2022

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

Published on: August 11, 2023

Area of Science:

Ophthalmology
Genetics
Vascular Biology

Background:

Branch retinal vein occlusion (BRVO) is a major cause of global vision impairment, affecting millions and projected to rise with an aging population.
BRVO results from retinal vein obstruction, leading to hemorrhages, leakage, and vision damage, influenced by both ocular and genetic factors.

Discussion:

Ocular risk factors include glaucoma, short axial length, and optic disc drusen, which contribute to venous compression and vascular anomalies.
Genetic predispositions, involving polymorphisms in coagulation, endothelial function, and inflammatory pathways (e.g., MTHFR C677T, Factor V Leiden), are critical in BRVO susceptibility.

Key Insights:

Glaucoma, short axial length, and optic disc drusen are identified ocular risk factors for BRVO.
Specific genetic polymorphisms and familial clustering highlight the role of genetic factors in BRVO development.
Understanding these combined risk factors is essential for personalized medicine and public health interventions.

Outlook:

Further research into genetic and molecular mechanisms is vital for advancing BRVO management.
Developing comprehensive strategies for early detection, prevention, and tailored treatments will improve patient outcomes.
Personalized treatment approaches based on individual ocular and genetic profiles hold promise for enhanced BRVO care.